BACKGROUND: Abdominal aortic aneurysm (AAA) is characterized by inflammatory cell accumulation in AAA lesions that produce inflammatory cytokines and advance its pathogenesis. Peripheral cytokines may predict the degree or risk of AAA. METHODS AND RESULTS: ELISA determined plasma interleukin-6 (IL6), IL10, IL17A, IFN-γ, and C-reactive protein (CRP) from 476 AAA patients and 200 controls. AAA patients had lower IL6, IFN-γ, IL10, IL17A, and higher CRP than controls. IL10 correlated positively with IFN-γ, IL17A, or IL6, but not CRP in control or AAA populations. IL10 associated negatively with systolic blood pressure, whereas CRP associated positively with diastolic blood pressure and body mass index. CRP was an independent AAA risk factor and correlated positively with aortic diameters before and after adjustments for other risk factors. IFN-γ, IL17A, and CRP correlated positively with cross-sectional AAA area after adjustment. IL10 correlated positively with AAA growth rate before and after adjustment. The risk of death doubled in AAA patients with CRP levels above the median. CONCLUSIONS: Reduced IFN-γ, IL10, and IL17A in AAA patients, positive correlations of IFN-γ and IL17A with cross-sectional AAA area, IL10 with AAA growth rate, and IL10 with IFN-γ and IL17A suggest combined Th1, Th2, and Th17 immune responses in human AAAs.
BACKGROUND:Abdominal aortic aneurysm (AAA) is characterized by inflammatory cell accumulation in AAA lesions that produce inflammatory cytokines and advance its pathogenesis. Peripheral cytokines may predict the degree or risk of AAA. METHODS AND RESULTS: ELISA determined plasma interleukin-6 (IL6), IL10, IL17A, IFN-γ, and C-reactive protein (CRP) from 476 AAA patients and 200 controls. AAA patients had lower IL6, IFN-γ, IL10, IL17A, and higher CRP than controls. IL10 correlated positively with IFN-γ, IL17A, or IL6, but not CRP in control or AAA populations. IL10 associated negatively with systolic blood pressure, whereas CRP associated positively with diastolic blood pressure and body mass index. CRP was an independent AAA risk factor and correlated positively with aortic diameters before and after adjustments for other risk factors. IFN-γ, IL17A, and CRP correlated positively with cross-sectional AAA area after adjustment. IL10 correlated positively with AAA growth rate before and after adjustment. The risk of death doubled in AAA patients with CRP levels above the median. CONCLUSIONS: Reduced IFN-γ, IL10, and IL17A in AAA patients, positive correlations of IFN-γ and IL17A with cross-sectional AAA area, IL10 with AAA growth rate, and IL10 with IFN-γ and IL17A suggest combined Th1, Th2, and Th17 immune responses in humanAAAs.
Authors: Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver Journal: Nat Immunol Date: 2005-10-02 Impact factor: 25.606
Authors: Christina Duftner; Rüdiger Seiler; Peter Klein-Weigel; Heike Göbel; Christian Goldberger; Christian Ihling; Gustav Fraedrich; Michael Schirmer Journal: Arterioscler Thromb Vasc Biol Date: 2005-04-21 Impact factor: 8.311
Authors: Joe Dawson; Gillian W Cockerill; Edward Choke; Anne-Maria Belli; Ian Loftus; Matt M Thompson Journal: J Vasc Surg Date: 2007-02 Impact factor: 4.268
Authors: Jan H N Lindeman; Hazem Abdul-Hussien; Alexander F M Schaapherder; J Hajo Van Bockel; Jan H Von der Thüsen; Dave L Roelen; Robert Kleemann Journal: Clin Sci (Lond) Date: 2008-06 Impact factor: 6.124
Authors: Jiusong Sun; Galina K Sukhova; Min Yang; Paul J Wolters; Lindsey A MacFarlane; Peter Libby; Chongxiu Sun; Yadong Zhang; Jian Liu; Terri L Ennis; Rebecca Knispel; Wanfen Xiong; Robert W Thompson; B Timothy Baxter; Guo-Ping Shi Journal: J Clin Invest Date: 2007-11 Impact factor: 14.808
Authors: Rachel K Middleton; Geraint M Lloyd; Matthew J Bown; Nicola J Cooper; Nicholas J London; Robert D Sayers Journal: J Vasc Surg Date: 2007-03 Impact factor: 4.268
Authors: Olesya A Puchenkova; Vladislav O Soldatov; Andrei E Belykh; OlgaYu Bushueva; Gennadii A Piavchenko; Artem A Venediktov; Nikolay K Shakhpazyan; Alexey V Deykin; Mikhail V Korokin; Mikhail V Pokrovskiy Journal: Biomark Insights Date: 2022-04-25